Brief Summary

The purpose of this surveillance (non-interventional) clinical study is to genotype the causative agents of rickettsioses in biological samples of patients from the regions of Russia. This is a solely observational study in the patients with diagnosed or suspected tick-borne rickettsioses, with no intervention to the routine treatment and diagnostic process. During the study the medical history, diseases progress and symptoms, as well as treatments are being registered in individual case report forms. The rests of the samples used for standard diagnostics (blood, plasma, buffy coat, or serum, and/or swab of the eschar) are being collected and afterwards analyzed for rickettsial genotypes. These data are being compared to the medical history and symptoms of the patients in order to identify clinical patterns specific for causative agents of rickettsioses. Informed consent from all patients or their legal representatives are being collecting. The study was approved by the ethical committee.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

24 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Apr 2023Dec 2026

Study Start

First participant enrolled

April 1, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 8, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

3.8 years

First QC Date

November 28, 2023

Last Update Submit

February 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Genetic identification of the rickettsia species

    Genetic identification of the rickettsia species causing rickettsioses, including new circulating genotypes

    up to 4 weeks

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Male and female patients of any age with diagnosed or suspected tick-born rickettsioses.

You may qualify if:

  • To be included in the study, the subject must meet all the following criteria:
  • Written informed consent by the subject (or their legal representative) to participate in the study;
  • Men and women of any age, including children, who:
  • have sought medical care (outpatient or inpatient) with suspected or diagnosed rickettsiosis; or have sought medical care (inpatient) with a history of tick bites and elevated body temperature (at least 37.2 °C lasting at least 48 hours).

You may not qualify if:

  • \- Inability or unwillingness of the subject (or their legal representative) to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

Chemal District Hospital

Chemal, Altai Republic, 649240, Russia

RECRUITING

Center for AIDS Prophylaxis and Treatment

Gorno-Altaysk, Altai Republic, 649002, Russia

RECRUITING

Choya District Hospital

Gusevka, Altai Republic, 649180, Russia

RECRUITING

Kosh-Agach District Hospital

Kosh-Agach, Altai Republic, 649780, Russia

RECRUITING

Mayma District Hospital

Mayma, Altai Republic, 649100, Russia

RECRUITING

Onguday District Hospital

Onguday, Altai Republic, 649440, Russia

RECRUITING

Ust-Kan District Hospital

Ust'-Kan, Altai Republic, 649450, Russia

RECRUITING

Ust-Koksa District Hospital

Ust'-Koksa, Altai Republic, 649490, Russia

RECRUITING

Ulagan District Hospital

Ust'-Ulagan, Altai Republic, 649750, Russia

RECRUITING

Altai State Medical University

Barnaul, Altayskiy Kray, 656038, Russia

RECRUITING

City Hospital No. 5

Barnaul, Altayskiy Kray, 656045, Russia

RECRUITING

Barnaul Regional Clinical Hospital for Emergency Medical Care No. 2

Barnaul, Altayskiy Kray, 656050, Russia

RECRUITING

Biysk Central City Hospital

Biysk, Altayskiy Kray, 659323, Russia

RECRUITING

Regional Infectious Diseases Clinical Hospital named after A.M. Nichoga

Astrakhan, Astrakhan Oblast, 414004, Russia

RECRUITING

Irkutsk State Medical University

Irkutsk, Irkutsk Oblast, 664003, Russia

RECRUITING

Irkutsk Regional Infectious Diseases Clinical Hospital

Irkutsk, Irkutsk Oblast, 664043, Russia

RECRUITING

City Clinical Hospital named after Professor A.M. Voyno-Yasenetsky

Khabarovsk, Khabarovskiy Kray, 680035, Russia

RECRUITING

Imeni Lazo District Hospital

Pereyaslavka, Khabarovskiy Kray, 682910, Russia

RECRUITING

Pskov Regional Infectious Diseases Clinical Hospital

Pskov, Pskov Oblast, 180016, Russia

RECRUITING

Republican Clinical Infectious Diseases Hospital

Abakan, Respublika Khakasiya, 655009, Russia

RECRUITING

Abakan Interdistrict Clinical Hospital

Abakan, Respublika Khakasiya, 655017, Russia

RECRUITING

Sayanogorsk Interdistrict Hospital

Sayanogorsk, Respublika Khakasiya, 655602, Russia

RECRUITING

Infectious Diseases Hospital

Kyzyl, Respublika Tyva, 667003, Russia

RECRUITING

Yakutia Republican Clinical Hospital

Yakutsk, Sakha, 677005, Russia

RECRUITING

MeSH Terms

Conditions

Rickettsia Infections

Condition Hierarchy (Ancestors)

Rickettsiaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsVector Borne Diseases

Study Officials

  • Alexey V. Kostarnoy, PhD

    Gamaleya Research Center of Epidemiology and Microbiology, Health Ministry of the Russian Federation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Petya G. Gancheva

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2023

First Posted

December 8, 2023

Study Start

April 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations